Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring yhoo.it/Ts0oSb

VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx bit.ly/WGFikk

uniQure Licenses RNA Interference Technology to Advance Huntington's Disease Program yhoo.it/11KjR76

Metabolic Biomarkers for Preventive Molecular Medicine bit.ly/QHOYgp

Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform yhoo.it/RaCQ91

Nanosphere Receives FDA Clearance for C. difficile Test goo.gl/i22mW

Amgen to Acquire the Gene-Hunting Firm deCODE goo.gl/sBSzI

Genalyte wins NIDDK grant for Type 1 diabetes assay development goo.gl/BlYqq

SynapDx Corporation Secures $6 Million to Advance Efforts in Early Detection of Autism goo.gl/Jqrk9

23andMe Raises More Than $50 Million in New Financing goo.gl/QK2a6

BG Medicine gains CE mark for cardiovascular Dx goo.gl/LdUCw

Exact Sciences heads to the FDA with cancer diagnostic goo.gl/ZerWR

Biocartis bags $44.5M Series D for molecular Dx commercialization goo.gl/iAA28

Cheap Dx spots lung cancer mutation ripe for Pfizer drug goo.gl/rml2O

FDA approves Quidel non-instrumented C difficile detection assay bit.ly/U6nYqO

Exclusive Agreement for Genetic Testing and Research Announced Between Dominion Diagnostics and LifeGen, Inc. bit.ly/ZIXy2c

Range of epigenetic immunoassays from VolitionRx now available for research use bit.ly/ZDgdwy

Roche's Rapid Mycoplasma Detection Test MycoTOOL Receives FDA Acceptance prn.to/T77YDE

NeoGenomics unveils Barrett's Esophagus FISH test in US bit.ly/XONoI7

Novartis arm licenses Trovagene gene patent for bit.ly/U1VziS